Relationship between glycated haemoglobin levels and mean glucose levels over time

D M Nathan1, H Turgeon, S Regan

  • 1Diabetes Center, Department of Biostatistics, Massachusetts General Hospital, 50 Staniford Street, Suite 340, Boston, MA 02114, USA. dnathan@Partners.org

Diabetologia
|September 14, 2007
PubMed

Insights

Glycated hemoglobin (HbA1c) strongly correlates with mean glucose levels measured by continuous glucose monitoring over 8-12 weeks. This study demonstrates that HbA1c can be reliably converted to average glucose levels for better diabetes management.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Clinical Chemistry

Background:

  • HbA1c is the standard measure for chronic glycemia, guiding diabetes treatment.
  • Daily diabetes management relies on capillary glucose readings (mmol/l).
  • A direct correlation between HbA1c and mean glucose levels is needed for treatment adjustments.

Purpose of the Study:

  • To determine the relationship between continuous glucose monitoring (CGM) and HbA1c levels.
  • To assess if HbA1c can be expressed in mmol/l, aligning with self-monitoring results.

Main Methods:

  • A longitudinal observational study involving 25 participants (22 with diabetes).
  • Continuous glucose monitoring (CGM) measured interstitial glucose every 5 minutes for 12 weeks.
  • HbA1c and capillary glucose levels were measured periodically to validate CGM accuracy.

Main Results:

  • HbA1c levels at 8 and 12 weeks showed a strong correlation (r=0.90) with preceding CGM data.
  • Both curvilinear and linear regression models accurately represented the relationship.
  • HbA1c values were successfully transformed into calculated mean glucose levels.

Conclusions:

  • HbA1c is a reliable indicator of average glycemia over the preceding 8-12 weeks.
  • Translating HbA1c into average glucose levels is feasible for clinical reporting and management.
Abstract

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...